The influence of consumers' preferences and perceptions of oral solid dosage forms on their treatment
- PMID: 22744843
- DOI: 10.1007/s11096-012-9667-6
The influence of consumers' preferences and perceptions of oral solid dosage forms on their treatment
Abstract
Background: Beyond the direct pharmacological effect of medicines, preferences and perceptions toward a particular oral solid dosage form (OSDF) play a crucial role in recovery and may reduce adherence to the prescribed treatment.
Objectives: This study conducted to investigate the most preferred OSDF and the degree to which swallowing solid medication is an issue, to assess perceptions of the therapeutic benefits of the OSDF, and to find predictors of the most preferred OSDF.
Method: A cross-sectional study, through convenience sample method, was conducted to survey consumers visiting community pharmacies in Baghdad, Iraq. Data was collected by self-administered and pre-piloted questionnaires, and analyzed using Statistical Package for Social Science. Multiple logistic regression analysis and Chi-square tests were used at alpha level = 0.05.
Results: A total of 1,000 questionnaire were included in the analysis. Of all respondents, 52.9 % preferred capsule among other OSDF and this preference varied significantly with a number of socio-demographic factors. Ease of swallowing solid medication was the main issue which resulted in preferences for a particular form. A negative perception of the therapeutic benefits of the OSDF was found among 89.1 % of the consumers. Multiple logistic regression analysis indicated that gender, ease of swallowing, and perceptions of the therapeutic benefits of the OSDF were significant predictors of capsule preferences.
Conclusions: Given the fact that consumers are the end users of medicines and their preferences may influence response to the treatment, efforts are worthwhile by the prescribers and medicines' manufactures to understand consumers' preferences of a particular dosage form in order to achieve successful therapy outcomes.
Similar articles
-
Acceptability of oral solid medicines in older adults with and without dysphagia: A nested pilot validation questionnaire based observational study.Int J Pharm. 2016 Oct 30;512(2):374-381. doi: 10.1016/j.ijpharm.2016.03.007. Epub 2016 Mar 9. Int J Pharm. 2016. PMID: 26970368
-
Softgels: consumer perceptions and market impact relative to other oral dosage forms.Adv Ther. 2000 Sep-Oct;17(5):213-21. doi: 10.1007/BF02853160. Adv Ther. 2000. PMID: 11186141
-
Swallowing difficulties with oral drugs among polypharmacy patients attending community pharmacies.Int J Clin Pharm. 2013 Dec;35(6):1130-6. doi: 10.1007/s11096-013-9836-2. Epub 2013 Aug 21. Int J Clin Pharm. 2013. PMID: 23963541
-
Dosage form modification and oral drug delivery in older people.Adv Drug Deliv Rev. 2018 Oct;135:75-84. doi: 10.1016/j.addr.2018.04.012. Epub 2018 Apr 13. Adv Drug Deliv Rev. 2018. PMID: 29660383 Review.
-
[Galenic forms for oral medication].Rev Infirm. 2012 Oct;(184):41-3. Rev Infirm. 2012. PMID: 23092084 Review. French.
Cited by
-
Patients' Preferences and Willingness to Pay for Solid Forms of Oral Medications-Results of the Discrete Choice Experiment in Polish Outpatients.Pharmaceutics. 2020 Mar 6;12(3):236. doi: 10.3390/pharmaceutics12030236. Pharmaceutics. 2020. PMID: 32155864 Free PMC article.
-
Identifying and addressing pill aversion in adults without physiological-related dysphagia: A narrative review.Br J Clin Pharmacol. 2022 Dec;88(12):5128-5148. doi: 10.1111/bcp.15463. Epub 2022 Aug 2. Br J Clin Pharmacol. 2022. PMID: 35849849 Free PMC article. Review.
-
Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence.Pharmaceutics. 2020 Jan 3;12(1):44. doi: 10.3390/pharmaceutics12010044. Pharmaceutics. 2020. PMID: 31947888 Free PMC article. Review.
-
Lignin and Cellulose Blends as Pharmaceutical Excipient for Tablet Manufacturing via Direct Compression.Biomolecules. 2019 Aug 28;9(9):423. doi: 10.3390/biom9090423. Biomolecules. 2019. PMID: 31466387 Free PMC article.
-
Lignin as a Bioactive Additive in Chlorzoxazone-Loaded Pharmaceutical Tablets.Molecules. 2025 Mar 23;30(7):1426. doi: 10.3390/molecules30071426. Molecules. 2025. PMID: 40286006 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical